Skip to main content
. 2021 Jul 13;38(10):2651–2661. doi: 10.1007/s10815-021-02271-5

Table 5.

ESTHER-1 and ESTHER-2 Trial Groups’ participating sites and principal investigators

Country Participating sites and principal investigatorsa
Belgium Herman Tournaye, UZ Brussel; Petra De Sutter, UZ Gent; Wim Decleer, AZ Jan Palfijn AV, Gent.
Brazil Alvaro Petracco, Fertilitat – Centro de Medicina Reproductiva, Porto Alegre; Edson Borges, Fertility – Centro de Fertilizacao Assistida, São Paulo; Caio Parente Barbosa, Instituto Ideia Fértil de Saúde Reproductiva, São Paulo.
Canada Jon Havelock, Pacific Centre for Reproductive Medicine, Burnaby, British Columbia; Paul Claman, Ottawa Fertility Centre, Ottawa, Ontario; Albert Yuzpe, Olive Fertility Centre, Vancouver, British Columbia.
Czech Republic Hana Visnova, IVF CUBE SE, Prague; Pavel Ventruba, Centre of Assisted Reproduction, Brno; Petr Uher, Institute of Reproductive Medicine and Genetics, Karlovy Vary; Milan Mrazek, GYNEM, Prague.
Denmark Anders Nyboe Andersen, The Fertility Clinic, Copenhagen University Hospital, Copenhagen; Ulla Breth Knudsen, The Fertility Clinic, Aarhus University Hospital, Skejby.
France Didier Dewailly, Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre; Anne Guivarc'h Leveque, Clinique Mutualiste La Sagesse.
Italy Antonio La Marca, University of Modena and Reggio Emilia, Modena; Enrico Papaleo, Centro Natalità San Raffaele, Milan.
Poland Waldemar Kuczynski, Kriobank, Bialystok; Katarzyna Kozioł, nOvum Fertility Clinic, Warsaw.
Russia Margarita Anshina, Centre of Reproduction & Genetics – LLC, Moscow; Irina Zazerskaya, Federal State Budgetary Institution “Federal Center of Heart, Blood & Endocrinology named after V.I. Almazov” of Ministry of Health of the Russian Federation, Saint Petersburg; Alexander Gzgzyan, Institute of Russian Academy of Medical Science Scientific Research Institute of Gynaecology and Obstetrics named after D.O. Ott of North-West Department of RAMS, Saint Petersburg; Elena Bulychova, State Budgetary Health Institution of Moscow Region “Moscow Regional Scientific Research Institute of Obstetrics & Gynaecology.”
Spain Victoria Verdú, Genefiv, Madrid; Pedro Barri, Hospital Universitario Quirón Dexeus, Barcelona; Juan Antonio García-Velasco, IVI Madrid, Madrid; Manuel Fernández-Sánchez, IVI Sevilla, Seville; Fernando Sánchez Martin, Ginemed, Seville; Ernesto Bosch, IVI Valencia, Valencia; José Serna, IVI Zaragoza, Zaragoza; Gemma Castillon; IVI Barcelona, Barcelona; Rafael Bernabeu, Instituto Bernabeu, Alicante; Marcos Ferrando, IVI Bilbao, Bilbao.
UK Stuart Lavery, Boston Place Clinic, London, England; Marco Gaudoin, Glasgow Centre for Reproductive Medicine, Glasgow, Scotland.

aIn total, 37 sites from 11 countries participated in ESTHER-1 and 32 of the 37 sites participated in ESTHER-2

ESTHER Evidence-based Stimulation Trial with Human rFSH in Europe and Rest of World